WHO Foundation and Novo Nordisk Launch Initiative to Tackle Childhood Obesity in India
The WHO Foundation and Novo Nordisk have announced the collaboration and it is aimed at tackling childhood obesity in India. This will done through the various awareness programs and preventive health strategies. This initiative will support efforts to strengthen obesity prevention measures and health system readiness across the country. This partnership will focus on developing a scalable school based health program designed to address rising obesity levels among children.
According to the World Health Organization (WHO) overweight and obesity now cause more deaths globally than underweight.
Obesity is linked to several serious noncommunicable diseases including cardiovascular disease and type 2 diabetes.
India has also witnessed the growing trend of obesity among children and adolescents.
Several Health experts warn that without early intervention.
According to them rising obesity rates could significantly increase the burden of lifestyle related diseases in the future.
The collaboration effort between the WHO Foundation and Novo Nordisk will focus on several preventive measures.
They are aimed at promoting healthier lifestyles among children.
These efforts are intended to create long term behavioural changes.
Key focus areas include,
Schools are expected to play a central role in the childhood obesity prevention program.
This initiative plans to integrate health education and screening into everyday school activities.
Health Experts believe that schools provide an effective platform for encouraging healthy habits.
They can do that by various balanced diets, regular physical activity and awareness about lifestyle diseases.
Early intervention in educational settings can help reduce obesity risks in the long term.
The collaboration comes at a time when the global demand for weight loss and diabetes medications has increased significantly.
Drugs such as Wegovy and Ozempic by Novo Nordisk and Mounjaro by Eli Lilly have gained global attention for treating obesity and diabetes in adults.
With patents on certain medicines like semaglutide nearing expiry in markets including India. They are now more affordable version are expected to enter the pharmaceutical market and they potentially increasing treatment options for obesity related conditions.
The WHO Foundation is an independent organization established in 2020 and headquartered in Geneva Switzerland.
Its mission is to support the work of the World Health Organization by mobilising funding and partnerships for global health initiatives.
The foundation collaborates with governments, private organizations and philanthropies to address health challenges such as disease prevention, health system strengthening and public health awareness.
Q. Which organizations have partnered to address childhood obesity in India?
A. UNICEF and WHO
B. WHO Foundation and Novo Nordisk
C. World Bank and WHO
D. NITI Aayog and WHO
Can you imagine a place where the city and the country are exactly the same.…
Recent seismic activity across the world has once again brought earthquakes into global headlines. On…
Current Affairs preparation plays an important role in scoring well in the RRB NTPC CBT-2…
The Gupta Empire of the Ancient India is often called as the "Golden Age of…
On 25th June, 2026 World Vitiligo Day observed worldwide and this day serves as the…
In India, issues such as gender discrimination, female foeticide, unequal opportunities, child marriage, and negative…